Monthly Archives: May 2006

The Dangers of a Recess Appointment for Dr. von Eschenbach

Related to yesterday’s posting, because of the unorthodox way in which Plan B was handled, Acting Commissioner Andrew C. von Eschenbach faces the prospect of not ever being confirmed (though he actually had nothing to do with the issue).  There … Continue reading

Posted in FDA Image | Comments Off

Good Time to Move on Plan B

Last week, former Acting Commissioner and former Commissioner Lester B. Crawford admitted in a deposition that he acted to pre-empt FDA staff from approving the OTC switch of Plan B, according to a report in the Baltimore Sun.  What he … Continue reading

Posted in FDA Policy, OTC Switches | Comments Off

Memorial Day

With an eye towards remembering those who have demonstrated the courage of their convictions, have a safe and pleasant Memorial Day. Share this:

Posted in Uncategorized | Comments Off

Weekly Roundup – 5-26-06

After a two-week hiatus, Weekly Roundup is back.  Bad Legislative Action – An amendment to a House appropriations bill that would have provided for greater FDA authority over drug safety in post-marketing studies was stripped from the legislation.  Expect hearings … Continue reading

Posted in Weekly Roundup | Comments Off

Vitamins, Canada and a Lesson for NIH

With proposals before Congress (see Legislative section to the right) to allow the FDA additional power to regulate the industry of vitamins and supplements, there have been recent developments of note. Last week, the National Institutes of Health held a … Continue reading

Posted in DSHEA, Vitamins and Supplements | Comments Off